Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,663 | 465 | 89.4% |
| Education | $593.93 | 23 | 5.5% |
| Travel and Lodging | $548.31 | 7 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,560 | 71 | $0 (2024) |
| Intuitive Surgical, Inc. | $901.90 | 16 | $0 (2018) |
| ABBVIE INC. | $865.46 | 40 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $633.46 | 33 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $605.83 | 18 | $0 (2024) |
| PFIZER INC. | $561.21 | 40 | $0 (2022) |
| Janssen Biotech, Inc. | $400.36 | 20 | $0 (2024) |
| Coloplast Corp | $312.68 | 18 | $0 (2022) |
| Merck Sharp & Dohme LLC | $306.99 | 12 | $0 (2024) |
| Teleflex LLC | $259.52 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,750 | 70 | Dendreon Pharmaceuticals LLC ($269.06) |
| 2023 | $1,685 | 69 | Dendreon Pharmaceuticals LLC ($251.14) |
| 2022 | $1,338 | 64 | ABBVIE INC. ($197.72) |
| 2021 | $1,154 | 51 | Teleflex LLC ($194.24) |
| 2020 | $305.15 | 18 | Astellas Pharma US Inc ($69.75) |
| 2019 | $1,314 | 79 | Astellas Pharma US Inc ($368.01) |
| 2018 | $2,170 | 88 | Intuitive Surgical, Inc. ($901.90) |
| 2017 | $1,090 | 56 | Astellas Pharma US Inc ($248.67) |
All Payment Transactions
495 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $26.31 | General |
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: HORMONE THERAPY | ||||||
| 12/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.48 | General |
| 11/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Pain Management | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/21/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Diagnostic Imaging | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: UROLOGY | ||||||
| 10/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $46.93 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.36 | General |
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Laborie Medical Technologies Corp. | Urgent PC Neuromodulation System (Device) | Food and Beverage | Cash or cash equivalent | $48.02 | General |
| Category: Urology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Oncology | ||||||
| 08/22/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Oncology | ||||||
| 08/19/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.03 | General |
| 08/09/2024 | Olympus America Inc. | URETERO-RENO VIDEOSCOPE (Device) | Food and Beverage | In-kind items and services | $41.64 | General |
| Category: Urology Gynecology | ||||||
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,436 | 3,051 | $855,656 | $164,607 |
| 2022 | 22 | 2,369 | 2,935 | $766,120 | $153,941 |
| 2021 | 24 | 2,324 | 2,846 | $786,420 | $164,387 |
| 2020 | 24 | 2,002 | 2,347 | $606,033 | $120,486 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 399 | 444 | $72,372 | $29,634 | 40.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 129 | 148 | $137,640 | $28,329 | 20.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 17 | 153 | $297,000 | $21,031 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 193 | $44,004 | $19,587 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $21,442 | $9,268 | 43.2% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 13 | 13 | $47,710 | $8,187 | 17.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 54 | $20,520 | $7,928 | 38.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 30 | 30 | $30,300 | $6,180 | 20.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 40 | $10,400 | $4,418 | 42.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 34 | 34 | $20,060 | $3,907 | 19.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 76 | $7,828 | $3,458 | 44.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 318 | 368 | $36,800 | $3,178 | 8.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 294 | 373 | $7,460 | $3,125 | 41.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 22 | $47,080 | $2,987 | 6.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 41 | $5,740 | $2,744 | 47.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 40 | $5,141 | $2,112 | 41.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,284 | $1,936 | 45.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 19 | $3,365 | $1,378 | 40.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 288 | 396 | $7,920 | $1,226 | 15.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 19 | $3,800 | $986.48 | 26.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 361 | 445 | $8,900 | $976.80 | 11.0% |
| 51703 | Complicated insertion of bladder tube | Facility | 2023 | 11 | 12 | $7,440 | $789.60 | 10.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 27 | $7,250 | $772.47 | 10.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $1,200 | $469.30 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 396 | 455 | $73,868 | $31,070 | 42.1% |
About Dr. Michael Milani, D.O
Dr. Michael Milani, D.O is a Urology healthcare provider based in La Grange Highlands, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982617056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Milani, D.O has received a total of $10,806 in payments from pharmaceutical and medical device companies, with $1,750 received in 2024. These payments were reported across 495 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($9,663).
As a Medicare-enrolled provider, Milani has provided services to 9,131 Medicare beneficiaries, totaling 11,179 services with total Medicare billing of $603,421. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location La Grange Highlands, IL
- Active Since 08/13/2006
- Last Updated 07/12/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1982617056
Products in Payments
- XTANDI (Drug) $931.67
- Da Vinci Surgical System (Device) $901.90
- PROVENGE (Drug) $628.83
- BOTOX (Biological) $414.51
- Xofigo (Drug) $357.62
- ORGOVYX (Drug) $298.05
- LUPRON DEPOT (Drug) $294.83
- KEYTRUDA (Biological) $276.63
- Nubeqa (Drug) $275.84
- MYRBETRIQ (Drug) $262.43
- ELIGARD (Drug) $257.19
- Xtandi (Drug) $246.56
- Myrbetriq (Drug) $213.43
- LYNPARZA (Drug) $206.42
- UroLift System (Device) $194.24
- NOCDURNA (Drug) $191.80
- ERLEADA (Drug) $173.47
- Androgel (Drug) $161.19
- SpeediCath (Device) $159.74
- ZYTIGA (Drug) $156.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in La Grange Highlands
Risha Foster, Md, MD
Urology — Payments: $9,677
Dr. Chirag Doshi, M.d, M.D
Urology — Payments: $8,466
Carol Rodgers, Np, NP
Urology — Payments: $3,360
Michael Moran, M.d, M.D
Urology — Payments: $46.38
George Moran, M.d, M.D
Urology